Back to search

Article

In Vivo Production of a Protein via the Delivery of Plasmid DNA by Computationally Designed Polymer Nanoparticles (PNP)

2025-02-19

Abstract excerpt

While monoclonal antibodies (mAbs) are a prominent class of pharmaceutical products there remain significant issues of cost, complexity, and especially delivery: concepts that overcome the need to infuse antibodies frequently are a desirable objective. An attractive approach is to deliver non-integrating DNA directly to muscle tissue, allowing the patient to act as their own so-called “protein factory.” Demonstrat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
35acf53f-4f0f-5494-9f4a-dc5b5eb12733
DOI
10.1101/2025.02.14.638338
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
In Vivo Production of a Protein via the Delivery of Plasmid DNA by Computationally Designed Polymer Nanoparticles (PNP)DOI 10.1101/2025.02.14.638338
Select a neighboring publication to make it the new centre.